WO1992019553A1 - Divalent silver halide bactericide - Google Patents

Divalent silver halide bactericide Download PDF

Info

Publication number
WO1992019553A1
WO1992019553A1 PCT/US1992/003987 US9203987W WO9219553A1 WO 1992019553 A1 WO1992019553 A1 WO 1992019553A1 US 9203987 W US9203987 W US 9203987W WO 9219553 A1 WO9219553 A1 WO 9219553A1
Authority
WO
WIPO (PCT)
Prior art keywords
divalent silver
halides
divalent
silver
water
Prior art date
Application number
PCT/US1992/003987
Other languages
French (fr)
Inventor
Marvin S. Antelman
Original Assignee
N. Jonas & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N. Jonas & Co., Inc. filed Critical N. Jonas & Co., Inc.
Publication of WO1992019553A1 publication Critical patent/WO1992019553A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/50Treatment of water, waste water, or sewage by addition or application of a germicide or by oligodynamic treatment
    • C02F1/505Treatment of water, waste water, or sewage by addition or application of a germicide or by oligodynamic treatment by oligodynamic treatment
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2103/00Nature of the water, waste water, sewage or sludge to be treated
    • C02F2103/42Nature of the water, waste water, sewage or sludge to be treated from bathing facilities, e.g. swimming pools

Definitions

  • the present invention relates to divalent silver (Agll) halide bactericides.
  • the bactericidal properties of soluble Ag(II) compounds is the subject of U.S. Patent #5,017,285 of the present inventor.
  • the inventor described the preparation of soluble Ag(II) compounds which are effective bactericides in swimming pool and industrial cooling tower waters. These compounds are prepared by dissolving divalent silver oxide, AgO, in certain acids such as phosphoric acid, which form stable Ag(II) complexes. In the course of experimenting with these complexes, it was found that halides precipitated Ag(II) halides from these solutions.
  • the primary object of this invention is to provide a source of bactericidally active divalent silver for application to waters utilized for industrial cooling water, swimming pool and hot tub applications which requires 100% kills of a specific standardized bacterium coliform strain within 10 minutes for swimming pools and hot tubs.
  • a further object of this invention is to provide for a source of divalent silver ions which will not precipitate silver halide out of water containing halide salts. Summary of the Invention This invention relates to methods for keeping the water in swimming pools, hot tubs and industrial cooling installations free from bacteria. Said methods relate to bactericidal agent additions of divalent silver halides, especially the chloride, bromide or iodide to said waters.
  • Divalent silver halides were prepared in the laboratory via various inorganic synthetic routes and were evaluated in the presence of persulfate ion, a known stabilizer for Ag(II) ions, to see whether they were effective at various concentrations in inhibiting bacterial growth.
  • the culture that was chosen for evaluation was E. Coli, and a test method based on EPA protocol AOAC 15th 1990:965:13 was utilized, which involves a culture of lOOk/cc and requires 100% kills within 10 minutes for a bacteri ⁇ ide to qualify in swimming pools.
  • the evaluations were performed in the presence of 10 L/cc potassium monopersulfate utilizing Oxone which is the registered trademark of said compound manufactured by Dupont Company.
  • the silver halides were also added to high salt content water with absolutely no precipitation occurring.
  • the silver halides were prepared essentially by three routes: 1) Precipitation from divalent silver nitrate solution with an alkaline metal halide; 2) Direct action of a hydrohalic acid with AgO; 3) Direct action of boiling hot alkaline metal halide solution on AgO.
  • Divalent silver nitrate was prepared by dissolving AgO in nitric acid.

Abstract

Divalent silver halides provide a source for divalent bactericidal silver ions in the presence of persulfate. The halides are especially effective when applied to water used in industrial cooling installations, hot tubs and swimming pools and will conform to stringent EPA requirements for waters utilized for bathing as in tubs and pools of 100 % kills of 100 K/cc E. Coli coliforms within 10 minutes, examplary of which are the chloride and bromide which give 100 % kills within 5 minutes. The halides, of course, can be used in salty water since they are solids immune from halide action that would otherwise precipitate soluble divalent silver from solution.

Description

DIVALENT SILVER HALIDE BACTERICIDE Background of the Invention The present invention relates to divalent silver (Agll) halide bactericides. The bactericidal properties of soluble Ag(II) compounds is the subject of U.S. Patent #5,017,285 of the present inventor. In said patent the inventor described the preparation of soluble Ag(II) compounds which are effective bactericides in swimming pool and industrial cooling tower waters. These compounds are prepared by dissolving divalent silver oxide, AgO, in certain acids such as phosphoric acid, which form stable Ag(II) complexes. In the course of experimenting with these complexes, it was found that halides precipitated Ag(II) halides from these solutions. It should be noted that the solubility of Ag(II) compounds is totally unrelated to those of Ag(I) in water. For example, Ag(II) sulfate is totally soluble compared to the partially soluble Ag(I) salt. Thus the fact that Ag(II) precipitates halides is not necessarily to be anticipated since the Ag(I) and Ag(II) chemistries are different and distinct despite the fact that they represent dissimilar states of the same element. It was also found that Ag(II) complexes had a greater tolerance for free halide in solution than Ag(I) . Accordingly, water sources containing 100 PPM of dissolved sodium chloride (NaCl) would not precipitate insoluble chloride from those solutions which are described in my aforementioned patent. However, water with substantially higher halide content precipitated silver halide. It was postulated that for those high halide waters, such as sea water used for swimming pools, brackish waters used in cooling towers, swimming pools maintained with calcium chloride for mineralization or mineralized hot tubs, Ag(II) halides could be useful provided they exhibited bactericidal properties since they are already insoluble and will not be prone to precipitation. This was highly desirable since tests conducted in a swimming pool with a high chloride content produced an aesthetically unacceptable curdy white precipitate of chloride when it was treated with an Ag(II) phosphate complex. Of course, since a divalent silver halide is effective and would by necessity have to be produced from a soluble bactericidally active Ag(II) complex, it would not be the first product of choice for low-salt or salt- free water treatment where said soluble Ag(II) complexes were the preferable product. However, there existed the possibility that direct action of a hydrohalic acid on Ago could yield end product Ag(II) halides even though the latter were insoluble. If this were possible, then said Ag(II) halides would be intrinsically competitive with the soluble Ag(II) complexes. Accordingly, it was found that Ag(II) halides are bactericidally active and that they could be prepared both directly and indirectly from AgO. Object of the Invention The primary object of this invention is to provide a source of bactericidally active divalent silver for application to waters utilized for industrial cooling water, swimming pool and hot tub applications which requires 100% kills of a specific standardized bacterium coliform strain within 10 minutes for swimming pools and hot tubs. A further object of this invention is to provide for a source of divalent silver ions which will not precipitate silver halide out of water containing halide salts. Summary of the Invention This invention relates to methods for keeping the water in swimming pools, hot tubs and industrial cooling installations free from bacteria. Said methods relate to bactericidal agent additions of divalent silver halides, especially the chloride, bromide or iodide to said waters. Divalent silver halides were prepared in the laboratory via various inorganic synthetic routes and were evaluated in the presence of persulfate ion, a known stabilizer for Ag(II) ions, to see whether they were effective at various concentrations in inhibiting bacterial growth. The culture that was chosen for evaluation was E. Coli, and a test method based on EPA protocol AOAC 15th 1990:965:13 was utilized, which involves a culture of lOOk/cc and requires 100% kills within 10 minutes for a bacteriσide to qualify in swimming pools. The evaluations were performed in the presence of 10 L/cc potassium monopersulfate utilizing Oxone which is the registered trademark of said compound manufactured by Dupont Company. The silver halides were also added to high salt content water with absolutely no precipitation occurring. The silver halides were prepared essentially by three routes: 1) Precipitation from divalent silver nitrate solution with an alkaline metal halide; 2) Direct action of a hydrohalic acid with AgO; 3) Direct action of boiling hot alkaline metal halide solution on AgO. Divalent silver nitrate was prepared by dissolving AgO in nitric acid. Other objects and features of the present invention will become apparent to those skilled in the art when the present invention is considered in view of the accompanying examples. It should, of course, be recognized that the accompanying examples illustrate preferred embodiments of the present invention and are not intended as a means of defining the limits and scope of the present invention. Description of the Preferred Embodiments As illustrative of the compositions of this invention are the following: EXAMPLE I Divalent silver nitrate was prepared by dissolving AgO containing 1.0 gram of silver for 5 minutes in 30% volume nitric acid (70% of specific gravity 1.42) . The dissolution proceeded over a 5-minute period at 75-80 degrees C. A yellowish brown solution resulted which was immediately diluted with water. The dissolution of AgO in nitric acid is illustrated by the following reaction: AgO + 2HN03 = Ag(N03)2 + H20 The resulting solution was reacted with an aliquot of sodium bromide. Beautiful crystals of divalent silver bromide precipitated from the solution which upon drying gave a yellow-green solid product. The preparation of divalent silver bromide by this route can be represented as follows: Ag(N03)2 + 2 NaBr = AgBr2 + 2 NaN03 When 5.0 PPM of Ag(II)Br were added to water containing 10 PPM of Oxone which had been adjusted to a pH of 7.5, 100% kills of the aforementioned E. Coli coliforms occurred according to the protocol described in the Summary of my invention after 5 and 10 minutes. This represented an actual silver concentration of 1.7 PPM which was effective as a swimming pool and hot tub disinfectant according to EPA protocol. EXAMPLE II Two samples of divalent silver chloride were prepared from AgO via alternative routes, the first by reaction of the oxide with a boiling solution of sodium chloride and the second by reaction of the oxide in the cold with concentrated hydrochloric acid. The reactions are respectively: AgO + 2NaCl + H20 = AgCl2 + 2 NaOH and AgO + 2HC1 = AgCl2+ H20 Samples of water containing 10 PPM of Oxone and adjusted to a pH=7.5 were treated with a 5 PPM of divalent silver chloride prepared by both methods. Both samples were submitted to the EPA protocol described in Example I. Both samples gave 100% kills after 5 and 10 minutes. This represented an actual silver concentration of 2.8 PPM which was effective as a swimming pool and hot tub disinfectant. As this invention may be embodied in several forms without departing from the spirit or essential characteristics thereof, the present embodiment is therefore illustrative and not restrictive, since the scope of the invention is defined by the appended claims rather than by the description preceding them, and all changes that fall within the metes and bounds of the claims or that form their functional as well as conjointly cooperative equivalents, are therefore intended to be embraced by these claims.

Claims

What is claimed is:
1. A method for controlling the growth of bacteria in the water of swimming pools, hot tubs and industrial cooling towers which comprises adding a divalent silver halide in the presence of an oxidizing agent so s to provide a source of divalent silver ions.
2. A method as claimed in claim 1 where the oxidizing agent is a persulfate. .
3. A method according to claim 1 which can be utilized in salt water without causing any precipitation of bactericidally active divalent silver ions.
PCT/US1992/003987 1991-05-09 1992-05-07 Divalent silver halide bactericide WO1992019553A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/697,783 US5078902A (en) 1991-05-09 1991-05-09 Divalent silver halide bactericide
US697,783 1991-05-09

Publications (1)

Publication Number Publication Date
WO1992019553A1 true WO1992019553A1 (en) 1992-11-12

Family

ID=24802520

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1992/003987 WO1992019553A1 (en) 1991-05-09 1992-05-07 Divalent silver halide bactericide

Country Status (3)

Country Link
US (1) US5078902A (en)
AU (1) AU2028492A (en)
WO (1) WO1992019553A1 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073382A (en) * 1991-05-09 1991-12-17 N. Jonas & Co., Inc. Divalent silver alkaline bactericide compositions
US5098582A (en) * 1991-05-09 1992-03-24 N. Jonas & Co., Inc. Divalent silver oxide bactericides
US5336499A (en) * 1992-01-10 1994-08-09 Antelman Technologies, Ltd. Molecular crystal device for pharmaceuticals
US5211855A (en) * 1992-01-24 1993-05-18 N. Jonas & Co., Inc. Method of treating water employing tetrasilver tetroxide crystals
US5223149A (en) * 1992-05-18 1993-06-29 N. Jonas & Co., Inc. Trivalent silver water treatment compositions
US5681575A (en) 1992-05-19 1997-10-28 Westaim Technologies Inc. Anti-microbial coating for medical devices
GEP20002074B (en) * 1992-05-19 2000-05-10 Westaim Tech Inc Ca Modified Material and Method for its Production
US5676977A (en) * 1994-09-22 1997-10-14 Antelman Technologies Ltd. Method of curing AIDS with tetrasilver tetroxide molecular crystal devices
US6210566B1 (en) * 1996-09-25 2001-04-03 Joseph A. King Nestable containers and improved water treatment materials
EP1041879B2 (en) * 1997-10-10 2012-03-21 Pure Bioscience Disinfectant and method of making
US6726936B1 (en) 1998-06-19 2004-04-27 Sumitomo Metal Mining Co., Ltd. Antimicrobial agents
GB2385790B (en) * 1998-06-19 2003-10-22 Sumitomo Metal Mining Co Antimicrobial agents
JP4558934B2 (en) * 1998-10-29 2010-10-06 住友金属鉱山株式会社 Antibacterial agent
US6565893B1 (en) 1999-02-17 2003-05-20 Worldwide Pure Water, Inc. Process for preparing a disinfectant containing suspended metals
US6224779B1 (en) * 1999-04-01 2001-05-01 Marshall L. Spector Inhibition of algae in swimming pools
US7261905B2 (en) * 1999-04-07 2007-08-28 Pure Bioscience Disinfectant and method of making
US6258385B1 (en) 1999-04-22 2001-07-10 Marantech Holding, Llc Tetrasilver tetroxide treatment for skin conditions
FR2792500B1 (en) * 1999-04-23 2004-05-21 Internat Redox Dev AQUEOUS COMPOSITION, IN PARTICULAR IN THE FORM OF GEL, BASED ON HO2F, ACIDS AND METAL IONS, PREPARATION METHOD, PARTICULARLY WHEN THE SAID IONS ARE AG2 + AND USE IN THE FIELD OF DISINFECTION AND / OR SURFACE TREATMENT
US6214299B1 (en) 1999-06-01 2001-04-10 Robert J. Holladay Apparatus and method for producing antimicrobial silver solution
US6383273B1 (en) 1999-08-12 2002-05-07 Apyron Technologies, Incorporated Compositions containing a biocidal compound or an adsorbent and/or catalyst compound and methods of making and using therefor
US6645531B1 (en) 2000-01-06 2003-11-11 Marantech Holding Llc Multivalent electron active compositions and methods of making and using same
US6669966B1 (en) 2000-01-06 2003-12-30 Marantech Holding Llc Compositions for facilitating skin growth and methods and articles using same
US20060105057A1 (en) * 2000-01-06 2006-05-18 Marantech Holding, Llc Compositions using tetrasilver tetroxide and methods for management of skin conditions using same
US6485755B1 (en) 2000-01-06 2002-11-26 Marantech Holding Methods of using electron active compounds for managing cancer
US20040022868A1 (en) * 2000-01-06 2004-02-05 Marantech Holding Llc Compositions using tetrasilver tetroxide and methods for management of skin conditions using same
US6346201B1 (en) 2000-04-05 2002-02-12 Icf Technologies, Inc. Ozonated solutions of tetrasilver tetroxide
US6890953B2 (en) * 2000-04-06 2005-05-10 Innovative Medical Services Process for treating water
US20040044073A1 (en) * 2002-08-31 2004-03-04 Innovative Medical Services Composition and process for treating acne
WO2005030028A2 (en) * 2003-04-28 2005-04-07 Aidance Medical Diagnostics, Llc Methods for detecting presence of cellular constituents
US7435438B1 (en) 2003-05-16 2008-10-14 Pure Bioscience Disinfectant and method of use
CA2526150C (en) * 2003-06-03 2014-05-06 American Biotech Labs Treatment of humans with colloidal silver composition
AU2004267997B2 (en) * 2003-08-28 2010-06-03 Pure Bioscience Silver dihydrogen citrate compositions comprising a second antimicrobial agent
US7582594B2 (en) * 2003-10-17 2009-09-01 Applied Research Associates, Inc. Dioxirane formulations for decontamination
US7560033B2 (en) * 2004-10-13 2009-07-14 E.I. Dupont De Nemours And Company Multi-functional oxidizing composition
US20050211612A1 (en) * 2004-03-25 2005-09-29 Mattson Roy W Jr Water suction purification device
US20060051430A1 (en) * 2004-09-07 2006-03-09 Arata Andrew B Silver dihydrogen citrate compositions
US7799234B2 (en) * 2007-04-09 2010-09-21 Innovation Services, Inc. In-line waste disinfection method
US7794606B2 (en) * 2007-04-09 2010-09-14 Innovation Services, Inc. Modular flameless waste treatment method
US9045718B2 (en) 2007-04-09 2015-06-02 Innovation Services, Inc. Residue cleaning composition and method
US8399028B2 (en) * 2008-08-14 2013-03-19 Exciton Technologies Inc. Antimicrobial silver solutions
WO2017034871A1 (en) 2015-08-21 2017-03-02 G&P Holding, Inc. Silver and copper itaconates and poly itaconates

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4055655A (en) * 1975-07-21 1977-10-25 National Research Laboratories Complexes of heavy metal ions and polyfunctional organic ligands used as antimicrobial agents
US4092245A (en) * 1977-04-07 1978-05-30 Goetz, Trustee Sylvia Liquid purification method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017295A (en) * 1990-05-01 1991-05-21 N. Jonas & Co., Inc. Divalent silver bactericide for water treatment

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4055655A (en) * 1975-07-21 1977-10-25 National Research Laboratories Complexes of heavy metal ions and polyfunctional organic ligands used as antimicrobial agents
US4092245A (en) * 1977-04-07 1978-05-30 Goetz, Trustee Sylvia Liquid purification method

Also Published As

Publication number Publication date
AU2028492A (en) 1992-12-21
US5078902A (en) 1992-01-07

Similar Documents

Publication Publication Date Title
US5078902A (en) Divalent silver halide bactericide
US6120698A (en) Balanced water purification composition
JP3346565B2 (en) Bivalent silver oxide fungicide
US6149821A (en) Balanced water purification system
US5017295A (en) Divalent silver bactericide for water treatment
US5089275A (en) Stabilized divalent silver bactericides
KR100567235B1 (en) Methods of preparing stabilized hypobromite and its use in water treatment to control microbial contamination
US5223149A (en) Trivalent silver water treatment compositions
US5141652A (en) Water treatment process
CN105967384A (en) Method for controlling generation of iodo-trihalomethanes in drinking water
US7045153B2 (en) Highly concentrated bromine compositions and methods of preparation
US7455859B2 (en) Highly concentrated bromine compositions and methods of preparation
JP3554749B2 (en) Disinfectant
RU2291836C2 (en) Hypobromous acid stabilized solutions
US5254526A (en) Method to prevent algae growth in pools and spas
Johnson Analytical problems in chlorination of saline water
JP5281465B2 (en) Bactericidal algicide composition, water-based bactericidal algicide method, and method for producing bactericidal algicide composition
AU2002219295B2 (en) Disinfecting peroxosilicated compound with scale preventive effect, preparation method and use thereof
CA2085167C (en) Disinfectant for use in aqueous systems
RU2213063C1 (en) Method for preparing bactericidal preparation
JPS6038198B2 (en) Stabilization method for residual chlorine
JP2004314038A (en) Disinfection method of water
JP2005131534A (en) Microbial damage prevention method
WO2004035483A1 (en) Stable n-bromo-2-pyrrolidine, methods to make same and use in water treatment

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BB BG BR CA CS FI HU JP KR NO PL RO RU

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BF BJ CF CG CH CI CM DE DK ES FR GA GB GN GR IT LU MC ML MR NL SE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA